pfizer - Search News

News

Pfizer Raises Profit Outlook

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

The Wall Street Journal on MSN · 1d

Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

MarketWatch on MSN · 1d

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

Pfizer, Q2

Seeking Alpha · 8h

Pfizer Q2: Dividends Speak Louder Than EPS

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate PFE stock a Sell.

Houston Chronicle · 1d

Pfizer: Q2 Earnings Snapshot

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 58 cents per share. The drugmaker posted revenue of $14.65 billion in the period, also topping Street forecasts.

Zacks.com on MSN · 1d

Pfizer Q2 Earnings Beat Estimates, Oncology Drives Top-Line Growth

Pfizer PFE reported second-quarter 2025 adjusted earnings per share of 78 cents, which comprehensively beat the Zacks Consensus Estimate of 58 cents per share. Earnings rose 30% year over year. Revenues came in at $14.

19hon MSN

1 Reason to Buy Pfizer (PFE) Stock

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

14h

Pfizer Pops Despite Looming Pharma Tariffs

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

21h

Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer

Shares in the data-software company were up 7.8% Tuesday after it posted higher quarterly results and [boosted its annual ...

1don MSN

Why Shares of Pfizer Soared Today

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

BioPharma Dive1d

Pharma prepared to work with Trump on DTC drug sales: Pfizer CEO

Pfizer's Albert Bourla told investors that major drugmakers are "ready to to roll up their sleeves" and build out more direct ...

5don MSN

Pfizer CEO attending $25 million fundraiser at Trump's golf club after president demands drug price cuts, sources say

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Vietnam Investment Review on MSN2h

Pfizer Romania Named Best Place to Work for 2025

86% align with Pfizer's commitment to social responsibility 83% rate HR practices as people-focused 94% alignment with best ...

4hon MSN

Jim Cramer Warns that Pfizer “Shareholder Base is Getting Very Restive”

Pfizer (NYSE:PFE) develops and sells biopharmaceutical products, including vaccines, treatments for infectious diseases, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results